Albarico, Phoebe O.
HRN: 17-13-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/04/2023
05/12/2023
IV
1.5gm
TID
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes